Earlier this month, a high-profile food researcher who’s recently come under fire announced a journal was retracting one of his papers for duplication. Today, a retraction appeared — for a 2002 study which contained “major overlap,” according to the journal.
The Journal of Sensory Studies has retracted a paper by Cornell’s Brian Wansink about how labeling of foods can affect how they taste, after determining it borrowed too heavily from a 2000 paper. Wansink is the first author on both studies.
In February, Lusine Abrahamyan, an assistant professor at the University of Toronto, was contacted by ResearchGate. Her name was listed on a 2016 paper in a heart journal, the site told her — was Abrahamyan indeed a co-author?
Um, no, she was not. In fact, before that moment, she didn’t know such a paper existed.
It turns out, Abrahamyan had supervised the thesis of the first author — who, she soon learned, had also published an identical paper in another heart journal. Both have since been retracted.
An internal review by Cornell University has concluded that a high-profile researcher whose work has been under fire made numerous mistakes in his work, but did not commit misconduct.
Starting to get bored of stings designed to expose the well-documented flaws in scientific publishing? Yeah, sometimes we are too. But another one just came across our desks, and we couldn’t help ourselves.
John McCool is neither a researcher nor a urologist. When received an unsolicited invitation to submit a paper to an open-access urology journal, however, he just couldn’t resist: He is the owner of a freelance scientific editing company, and has long been concerned about so-called predatory journals, which often publish sub-par papers as long as authors pay. And he loves the TV show “Seinfeld.”
Like many others before him, McCool decided to punk the journal by submitting a fake paper. He told us:
A high-profile pediatric oncologist quietly left his former institution in 2015 after it concluded his clinical trials had been affected by significant “administrative problems.” But now the results of the university’s investigations and what followed have become public, after a paper in Belgium published a series of news reports last month.
We’re still hazy on some details of the case. The recent news reports allege that Van Gool started some clinical trials without proper ethical approvals and informed consent, and may have misled patients and their families about the benefits and potential side effects of his experimental treatment. Meanwhile, the CEO University Hospitals Leuven (UZLeuven) told us that Stefaan Van Gool, who had appointments at both the hospital and the university (KULeuven), left the hospital in 2015 as a result of administrative problems, but did not disclose the specific nature of these issues.
For the past 15 years or so, Van Gool has been developing and studying a vaccine to treat various cancers, initially at UZLeuven and, after September 2015, at a private clinic in Germany. Today, patients travel to his private clinic from all over the world and pay tens of thousands of dollars to receive the vaccine. But according to Flemish daily newspaper De Standaard, several years ago, UZLeuven began investigating his research and patient care practices. The outcome of these investigations was kept private until last month, after De Standaard published its reports.
Marc Decramer, the CEO of UZLeuven, confirmed that Van Gool left the hospital in 2015 and the university in 2016,but did not provide the specific reasons for his exit:
According to an internal email to staff forwarded to us last year, the university concluded that Robert Ryan had misrepresented clinical data and images in 12 different publications. The first retraction, published by Molecular Microbiology, cites image duplications in multiple figures.
A researcher in Germany has been banned from seeking money from the largest independent research funder in the country for five years after an investigation by her former employer found her guilty of misconduct.
A spokesperson for the DFG told us the agency funds more than 30,000 projects per year, and since 1998, has announced a ban due to data manipulation or misconduct only 10 times.
A Swedish university has concluded that two professors studying tissue engineering are guilty of misconduct in two published papers, including a 2012 study in The Lancet.
Last July, Joseph Hilgard, a postdoctoral fellow at the Annenberg Public Policy Center at the University of Pennsylvania, saw an article in Gifted Child Quarterly that made him do a double take. Hilgard, who is studying the effects of violent media on aggressive behavior, said the results of the 2016 paper “caused me some alarm.”
The research—led by corresponding author Brad J. Bushman, a professor of communication and psychology at The Ohio State University (OSU)—showed that gifted and non-gifted children’s verbal skills dropped substantially after watching 12 minutes of a violent cartoon. The violent program had a greater impact on the gifted children, temporarily eliminating the pre-video verbal edge they displayed over their non-gifted peers.
To Hilgard, the results suggested that violent media can actually impair learning and performance. But the effect size was huge — so big, Hilgard thought it had to be a mistake. This, plus other questions, prompted Hilgard to contact the authors and the journal. Unfortunately, once he got a look at the data — collected by a co-author in Turkey who became unreachable after the recent coup attempt — the questions didn’t go away. So the journal decided to retract the paper.
Bushman’s body of work has continually supported the idea that violent media increases aggressive behavior, including a controversial 2012 study “Boom, Headshot!” that was retracted earlier this year.
Two journals have retracted two papers by the same group within months of each other, after editors were independently tipped off that they contained duplicated figures representing different experiments.
The two papers were published by PLOS ONE and The Egyptian Journal of Biochemistry and Molecular Biology (EJBMB) in 2015 and 2014, respectively. According to the PLOS ONE paper’s corresponding author, last author Saad A. Noeman from Tanta University in Egypt used the same Figure 1 in both papers, along with another 2013 paper in EJBMB.
Corresponding author Yasser S. El-Sayed, head of the Department of Forensic Medicine and Toxicology at Damanhour University in Egypt, told us he learned of this issue after a reader brought the figure manipulation and duplication concerns to PLOS ONE’s attention.
El-Sayed said that he tried to figure out what had happened.